Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H14ClN3OS |
| Molecular Weight | 259.756 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)C(=O)CSC1=NN=C(Cl)C=C1
InChI
InChIKey=SSLKKMZJCJBOML-UHFFFAOYSA-N
InChI=1S/C10H14ClN3OS/c1-3-14(4-2)10(15)7-16-9-6-5-8(11)12-13-9/h5-6H,3-4,7H2,1-2H3
| Molecular Formula | C10H14ClN3OS |
| Molecular Weight | 259.756 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Efficacy and safety of compound azintamide on dyspepsia symptoms in a multicentre self-controlled trial]. | 2008-11 |
|
| Gas-liquid chromatographic determination of azintamide (Ora-gallin) in pharmaceutical formulations. | 1985-05-24 |
|
| [Azintamid as a therapeutic agent in psoriasis vulgaris - a therapeutic study]. | 1983 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19080231
Two tablets of compound azintamide were administered orally following a meal, tid for 2 weeks
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 07:55:32 GMT 2025
by
admin
on
Wed Apr 02 07:55:32 GMT 2025
|
| Record UNII |
ACZ6L64B41
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C66913
Created by
admin on Wed Apr 02 07:55:32 GMT 2025 , Edited by admin on Wed Apr 02 07:55:32 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
71105
Created by
admin on Wed Apr 02 07:55:32 GMT 2025 , Edited by admin on Wed Apr 02 07:55:32 GMT 2025
|
PRIMARY | |||
|
ACZ6L64B41
Created by
admin on Wed Apr 02 07:55:32 GMT 2025 , Edited by admin on Wed Apr 02 07:55:32 GMT 2025
|
PRIMARY | |||
|
DB13992
Created by
admin on Wed Apr 02 07:55:32 GMT 2025 , Edited by admin on Wed Apr 02 07:55:32 GMT 2025
|
PRIMARY | |||
|
291837
Created by
admin on Wed Apr 02 07:55:32 GMT 2025 , Edited by admin on Wed Apr 02 07:55:32 GMT 2025
|
PRIMARY | |||
|
100000086085
Created by
admin on Wed Apr 02 07:55:32 GMT 2025 , Edited by admin on Wed Apr 02 07:55:32 GMT 2025
|
PRIMARY | |||
|
217-384-2
Created by
admin on Wed Apr 02 07:55:32 GMT 2025 , Edited by admin on Wed Apr 02 07:55:32 GMT 2025
|
PRIMARY | |||
|
DTXSID50171370
Created by
admin on Wed Apr 02 07:55:32 GMT 2025 , Edited by admin on Wed Apr 02 07:55:32 GMT 2025
|
PRIMARY | |||
|
275
Created by
admin on Wed Apr 02 07:55:32 GMT 2025 , Edited by admin on Wed Apr 02 07:55:32 GMT 2025
|
PRIMARY | |||
|
SUB05658MIG
Created by
admin on Wed Apr 02 07:55:32 GMT 2025 , Edited by admin on Wed Apr 02 07:55:32 GMT 2025
|
PRIMARY | |||
|
2063
Created by
admin on Wed Apr 02 07:55:32 GMT 2025 , Edited by admin on Wed Apr 02 07:55:32 GMT 2025
|
PRIMARY | |||
|
m1019
Created by
admin on Wed Apr 02 07:55:32 GMT 2025 , Edited by admin on Wed Apr 02 07:55:32 GMT 2025
|
PRIMARY | Merck Index | ||
|
C74232
Created by
admin on Wed Apr 02 07:55:32 GMT 2025 , Edited by admin on Wed Apr 02 07:55:32 GMT 2025
|
PRIMARY | |||
|
1830-32-6
Created by
admin on Wed Apr 02 07:55:32 GMT 2025 , Edited by admin on Wed Apr 02 07:55:32 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104678
Created by
admin on Wed Apr 02 07:55:32 GMT 2025 , Edited by admin on Wed Apr 02 07:55:32 GMT 2025
|
PRIMARY | |||
|
402580
Created by
admin on Wed Apr 02 07:55:32 GMT 2025 , Edited by admin on Wed Apr 02 07:55:32 GMT 2025
|
PRIMARY | RxNorm |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |